Yahoo Finance • 2 days ago
What Happened? A number of stocks jumped in the afternoon session after news of a new government prescription drug policy and a landmark deal with Pfizer eased investor concerns over stricter pricing regulations. The pharmaceutical and b... Full story
Yahoo Finance • 5 days ago
TORONTO, Sept. 29, 2025 (GLOBE NEWSWIRE) -- NEO Battery Materials Ltd. (“NEO” or the “Company”) (TSXV: NBM) (OTC: NBMFF), a low-cost, silicon-enhanced battery developer that enables longer-running, rapid-charging batteries for drones, ro... Full story
Yahoo Finance • 10 days ago
Fred Alger Management, an investment management company, released its “Alger Weatherbie Specialized Growth Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. Initial volatility in April stemmed from inc... Full story
Yahoo Finance • 12 days ago
TORONTO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- NEO Battery Materials Ltd. (“NEO” or the “Company”) (TSXV: NBM) (OTC: NBMFF), a low-cost, silicon-enhanced battery developer that enables longer-running, rapid-charging batteries for drones, ro... Full story
Yahoo Finance • 24 days ago
NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (NASDAQ: NEO). Such investors are advised to contact Danielle Peyton at new... Full story
Yahoo Finance • last month
On Friday, the District Court for the Middle District of North Carolina issued a ruling invalidating specific claims in two patents that Natera Inc. (NASDAQ:NTRA) asserted against NeoGenomics, Inc.'s (NASDAQ:NEO) v1.1 RaDaR test. Natera s... Full story
Yahoo Finance • last month
Check out the companies making the biggest moves midday: Petco Health & Wellness — The pet store and veterinary services provider surged 22% after raising its full-year adjusted EBITDA guidance. Second-quarter earnings per share topped ana... Full story
Yahoo Finance • last month
[Legal rights concept Statue of Lady Justice holding scales of justice] deepblue4you * NeoGenomics (NASDAQ:NEO [https://seekingalpha.com/symbol/NEO]) shares climbed ~20% in the premarket on Friday after the company announced a major vic... Full story
Yahoo Finance • last month
TORONTO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Neo Performance Materials Inc. ("Neo" or the "Company") (TSX: NEO) (OTCQX: NOPMF), based in Toronto, focused on advanced industrial materials, today announced that Jonathan Baksh, Executive Vice... Full story
Yahoo Finance • last month
NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (NASDAQ: NEO). Such investors are advised to contact Danielle Peyton at newac... Full story
Yahoo Finance • last month
[Medical industry stock market graph chart] Rasi Bhadramani Hedge funds increased their overweight positioning in health care (NYSEARCA:XLV [https://seekingalpha.com/symbol/XLV]) despite a 7% decline in the sector during the second quarte... Full story
Yahoo Finance • 2 months ago
NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (NASDAQ: NEO). Such investors are advised to contact Danielle Peyton at newa... Full story
Yahoo Finance • 2 months ago
Dublin, Aug. 06, 2025 (GLOBE NEWSWIRE) -- The "Legal AI Software - Company Evaluation Report, 2025" has been added to ResearchAndMarkets.com's offering. The Legal AI Software Companies Quadrant is a comprehensive industry analysis th... Full story
Yahoo Finance • 2 months ago
Investing.com - BTIG downgraded Neogenomics (NASDAQ:NEO) from Buy to Neutral on Wednesday, citing concerns about management credibility and product portfolio alignment. The stock, currently trading at $5.25, has declined over 20% in the pa... Full story
Yahoo Finance • 2 months ago
Earnings Call Insights: NeoGenomics (NEO) Q2 2025 MANAGEMENT VIEW * CEO Anthony P. Zook stated, "Revenue for Q2 was $181 million, slightly below our second quarter guidance range, though still representing double-digit growth of 10% ye... Full story
Yahoo Finance • 2 months ago
What Happened? Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) fell 3.8% in the afternoon session after weakness in the healthcare sector became pronounced following a poor sales report from a key competitor. The negative... Full story
Yahoo Finance • 2 months ago
* NeoGenomics press release [https://seekingalpha.com/pr/20180493-neogenomics-reports-second-quarter-2025-results] (NASDAQ:NEO [https://seekingalpha.com/symbol/NEO]): Q2 Non-GAAP EPS of $0.03 beats by $0.01. * Revenue of $181.3M (+10.2... Full story
Yahoo Finance • 2 months ago
* NeoGenomics (NASDAQ:NEO [https://seekingalpha.com/symbol/NEO]) is scheduled to announce Q2 earnings results on Tuesday, July 29th, before market open. * The consensus EPS Estimate is $0.02 [https://seekingalpha.com/symbol/NEO/earning... Full story
Yahoo Finance • 2 months ago
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied... Full story
Yahoo Finance • 2 months ago
Au titre du contrat de liquidité confié par NEOLIFE à TSAF – Tradition Securities And Futures, les moyens suivants figuraient au compte de liquidité en date du 30/06/2025 : 148 729 actions NEOLIFE,41 925,55 €. Il est rappelé que, lors du... Full story